ABIVAX (EPA:ABVX) | WebDisclosure

Basculer en Français

11046	Companies
242189	Keywords
170558	Articles
130377	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 10/06/2025 at 10:00, 11 months 16 days ago

Abivax annonce la présentation des derniers résultats des essais d'induction ABTECT de 8 semaines dans la population de patients avec et sans réponse inadéquate antérieure aux thérapies avancées
Abivax annonce des résultats positifs des essais ABTECT pour le traitement de la rectocolite hémorragique, avec présentation lors de la Semaine UEG à Berlin. Conférence téléphonique organisée par Abivax

Abivax Obefazimod Rectocolite Hémorragique Essais Cliniques Semaine UEG
BRIEF

published on 10/05/2025 at 17:05, 11 months 16 days ago

Abivax présente les résultats prometteurs de l'essai ABTECT de 8 semaines

Abivax Obefazimod Rectocolite Hémorragique Essais Cliniques Données De Sécurité
BRIEF

published on 10/05/2025 at 17:05, 11 months 16 days ago

Abivax Presents Promising 8-Week ABTECT Trial Results

Abivax Obefazimod Ulcerative Colitis Clinical Trials Safety Data
PRESS RELEASE

published on 10/05/2025 at 17:00, 11 months 16 days ago

Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data
Abivax announces positive results from Phase 3 ABTECT 8-Week Induction Trials on obefazimod for ulcerative colitis treatment with no new safety concerns identified, to present further abstract on October 6

Abivax Obefazimod Ulcerative Colitis Phase 3 Trial Safety Data
PRESS RELEASE

published on 10/05/2025 at 17:00, 11 months 16 days ago

Abivax annonce la présentation des derniers résultats de l'essai ABTECT de 8 semaines avec des données de tolérance actualisées
Abivax annonce la présentation des derniers résultats de l'essai ABTECT de 8 semaines avec des données de tolérance actualisées lors de la Semaine UEG à Berlin. Obefazimod atteint les critères clés d'évaluation dans le traitement de la rectocolite hémorragique

Abivax Résultats Rectocolite Hémorragique Essai Clinique Tolérance
BRIEF

published on 10/03/2025 at 11:59, 11 months 19 days ago

JP Morgan Chase & Co. franchit le seuil des 5% chez ABIVAX

Droits De Vote Franchissement De Seuil Actions Abivax JP Morgan
BRIEF

published on 10/03/2025 at 11:59, 11 months 19 days ago

JP Morgan Chase & Co. crosses the 5% threshold at ABIVAX

Voting Rights Actions Abivax Threshold Crossing JP Morgan
PRESS RELEASE

published on 10/03/2025 at 11:54, 11 months 19 days ago

Franchissement de seuil
JP Morgan Chase & Co. notifies increase to 5.64% voting rights in ABIVAX via indirect ownership. Details provided in threshold crossing declaration under article L. 233-7 of French Commercial Code

Abivax JP Morgan Chase Article L. 233-7 5.64% Threshold Crossing Declaration
BRIEF

published on 09/29/2025 at 22:10, 11 months 22 days ago

Abivax Presents New Findings on Obefazimod at UEG 2025

Abivax Obefazimod Ulcerative Colitis Phase 3 Trials UEG Meeting
BRIEF

published on 09/29/2025 at 22:10, 11 months 22 days ago

Abivax présente de nouvelles découvertes sur l'obéfazimod à l'UEG 2025

Abivax Obefazimod Rectocolite Hémorragique Essais De Phase 3 Réunion De L'UEG

Accesswire

Published on 09/22/2026 at 14:00, 54 minutes ago

GameSquare and Chartis Announce Strategic Data Partnership to Measure Brand and Creator Impact for User-Generated Content (UGC) Across Gaming
Published on 09/22/2026 at 14:00, 54 minutes ago

374Water to Present New Supercritical Water Oxidation Destruction Data at WEFTEC 2026
Published on 09/22/2026 at 14:00, 54 minutes ago

NuRAN Wireless to Pilot Starlink LEO Satellite Backhaul for Rural 4G Expansion and Edge AI Enablement
Published on 09/22/2026 at 13:45, 1 hour 9 minutes ago

Galway Metals Announces $14 Million Brokered Private Placement Led by Michael Gentile
Published on 09/22/2026 at 13:30, 1 hour 24 minutes ago

Silver X Increases Measured and Indicated Resources 173% to 10.4 Mt at 213 g/t AgEq (70.8 Moz AgEq) and Inferred Resources 43% to 21.6 Mt at 252 g/t AgEq (180.9 Moz AgEq)

View all ACCESSWIRE

EQS Group

Published on 09/22/2026 at 14:38, 15 minutes ago

Fuller, Smith & Turner PLC: Director / PDMR Shareholding
Published on 09/22/2026 at 14:33, 20 minutes ago

EPH Group AG develops exclusive luxury resort with around 300 beds in Burgenland, Austria
Published on 09/22/2026 at 14:17, 36 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 09/22/2026 at 14:17, 37 minutes ago

Form 8.3 - The Vanguard Group, Inc.: DCC plc
Published on 09/22/2026 at 14:16, 37 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc

Les Echos

Published on 09/21/2026 at 18:19, 20 hours 35 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 14 au 18 septembre 2026
Published on 09/21/2026 at 18:19, 20 hours 35 minutes ago

Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 20 hours 52 minutes ago

Partnership agreement signed between Manitou Group and HD Construction Equipment
Published on 09/21/2026 at 17:46, 21 hours 8 minutes ago

WEB SA - STATUTORY HALF-YEAR RESULTS AS OF 30/06/2026
Published on 09/21/2026 at 17:46, 21 hours 8 minutes ago

WEB SA - RESULTATS SEMESTRIELS STATUTAIRES AU 30/06/2026

View all LES ECHOS COMFI WIRE